A randomized trial comparing INR monitoring devices in patients with anticoagulation self-management: evaluation of a novel error-grid approach

[1]  H. Völler,et al.  Performance evaluation of the new CoaguChek XS system compared with the established CoaguChek system by patients experienced in INR-self management , 2007, Thrombosis and Haemostasis.

[2]  R. Perera,et al.  Self-monitoring of oral anticoagulation: a systematic review and meta-analysis , 2006, The Lancet.

[3]  H. Völler,et al.  Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation. , 2005, International journal of cardiology.

[4]  H. Völler,et al.  Analytical Performance of the New Coagulation Monitoring System INRatio™ for the Determination of INR Compared with the Coagulation Monitor Coaguchek® S and an Established Laboratory Method , 2004, Journal of Thrombosis and Thrombolysis.

[5]  H. Völler,et al.  Self management of oral anticoagulation with the IN Ratio system: impact of a structured teaching program on patient's knowledge of medical background and procedures , 2004, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[6]  A. Berghold,et al.  Systematic review of studies of self-management of oral anticoagulation , 2004, Thrombosis and Haemostasis.

[7]  P. Sawicki,et al.  Self‐management of oral anticoagulation: long‐term results , 2003, Journal of internal medicine.

[8]  J. Jespersen,et al.  Reliability of international normalised ratios from two point of care test systems: comparison with conventional methods , 2003, BMJ : British Medical Journal.

[9]  H. Halkin,et al.  Potential dosing errors using portable prothrombin time monitoring devices , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[10]  U. Taborski,et al.  Equivalence of Capillary versus Venous INR Results and Patient- versus Professional-determined INR Values Using the CoaguChek® S System , 2002, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[11]  A. M. H. P. V. D. Besselar,et al.  A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin. , 2000 .

[12]  B H Ginsberg,et al.  A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. , 2000, Diabetes care.

[13]  P. Sawicki,et al.  A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. , 1999, JAMA.

[14]  R. White,et al.  College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of oral anticoagulant therapy. , 1998, Archives of pathology & laboratory medicine.

[15]  D. Gough,et al.  Reservations on the Use of Error Grid Analysis for the Validation of Blood Glucose Assays , 1997, Diabetes Care.

[16]  E. Mascha,et al.  Accuracy of laboratory and portable monitor international normalized ratio determinations. Comparison with a criterion standard. , 1995, Archives of internal medicine.

[17]  J. Hirsh,et al.  Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. , 1993, Archives of internal medicine.

[18]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[19]  J. Pennebaker,et al.  Accuracy of Perceiving Blood Glucose in IDDM , 1985, Diabetes Care.

[20]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.

[21]  J. Hirsh,et al.  Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. , 2001, Chest.